Translational research

Translational research projects encourage collaborations between basic and clinical research. Their goal is to study cells and their interactions with the environment, and in so doing to provide new impulses for novel therapies and clinical approaches in order to be able to act on the causes of cellular malfunction.  

Financial support for translational cancer research projects is possible thanks to:

"Allocated funds" - These funds are specifically created for each project. They come from private donations and must be used for the predetermined purpose. The Foundation guarantees that donations are used in full to finance the project to which they have been allocated.

“ISREC chairs” - These are created to offer young professors affiliated to the EPFL (School of Life Sciences - ISREC) or to a Swiss University (Faculty of biology or medicine) the opportunity to launch their career in research. They are financed by the fortune of the Foundation.

Translational research - ongoing projects

Customizing treatment in cancer patients & uncovering cancer vulnerabilities

Customizing treatment in cancer patients & uncovering cancer vulnerabilities.

More information

Developing off-the-shelf allogeneic chimeric antigen receptor T cells for childhood leukemia

This “allocated fund” derived from a donation of the Empiris charitable umbrella foundation was granted to Prof. Caroline Arber (CHUV) in April 2022…

More information

Targeting novel molecular networks underlying bladder cancer recurrence and progression

This “allocated fund” was granted to Prof. Camilla Jandus (University of Geneva) and Prof. Grégory Verdeil (University of Lausanne) in April 2022 for…

More information

News & Events

Posted on

The ISREC Foundation is pleased to support the next AGORA workshop dedicated to multimodal imaging.

Read more
Posted on

Congratulations to Prof. Johanna Joyce and her teams for the publication in the distinguished Cell Reports Medicine journal. The study analyzed brain…

Read more
Posted on

Congratulations to Prof. Denis Migliorini, M.D., holder of the ISREC Foundation’s Brain Tumor Immunology Chair, and his team: along with Prof. Andrea…

Read more
Posted on

FLASH radiotherapy, an innovative and interdisciplinary technology, is perfectly in line with our goal of supporting translational cancer research. …

Read more